HOME   >   ȸ/м   >  м   >  ӻ
ӻко м
2017 58 ȸ мȸ ȳ
2017.05.26 - 2017.05.27
۾
÷

????:2017??5??26??? ~27????

????:?울 그랜?호??????

?페?? :http://www.hematology.or.kr/abstract/

The 58th Spring Meeting of the Korean Society of Hematology


MAY 26th (Friday)
?Room ARoom BRoom CRoom D
(Diamond Hall, 3F)
8:00Registration
8:50Opening Remark
09:00-10:00Educational Session I: Consultative HematologyEducation Session II: Minimal Residual DiseaseEducational Session III: Lymphoproliferative Disorders in Special Conditions?
Periprocedual hemostatic management of bleeding disorders

Won-Sik Lee (Inje Univ.)

MRD detection in AML

Sang Mee Hwang
(Seoul National Univ.)

Adult lymphoproliferative disorders other than PTLD

Jeong-Ok Lee
(Seoul National Univ.)

Therapeutic apheresis in practice

Chung Hyun Nahm
(Inha Univ.)

MRD measurement in ALL by flow cytometry

Chan-Jeoung Park
(Univ. of Ulsan)

Optimal treatment for PTLD

Jae-Ho Yoon
(The Catholic Univ. of Korea)

Imaging and interventionin DVT

?남??(?남??)

Minimal residual disease in MM

JeongYeal Ahn
(Gachon Univ.)

Lymphoproliferative disease and malignancies in primary immunodeficiency

Hyery Kim (Univ. of Ulsan)

10:00-10:10Break
10:10-10:50Plenary Lecture I

Ravi Bhatia (Univ. of Alabama at Birmingham, USA)

10:50-11:10Coffee Break
11:10-12:10Oral Presentation IOral Presentation IIOral Presentation IIIOral Presentation IV
12:10-13:00Satellite Symposium I [Luncheon]Satellite Symposium II [Luncheon]? 
Efficacy and safety of new intravenous immunoglobulin product, IVIG-SN 10%, in patients with primary ITP

Doyeun Oh (CHA Univ.)

Do genetic abnormalities influence treatment decisions in ET and PV?

Carlos Besses Raebel (Hospital del Mar-IMIM, Spain)

13:00-14:20Scientific Session I: Cancer GenomicsScientific Session II: Regulation of Normal and Malignant HematopoiesisScientific Session III: Clonal Evolution of Hematologic Diseases
Functional insights of somatic mutations from pan-cancer genome analyses

Tae-Min Kim
(The Catholic Univ. of Korea)

Regulation of HSC aging and rejuvenation by thiroedoxin-interacting protein-p38 axis

Inpyo Choi (KRIBB)

The clonal origins of leukemic progression of myelodysplasia

Jae-Sook Ahn


(Chonnaml National Univ.)

Genomic prediction of response to immunotherapy

Jung Kyoon Choi (KAIST)

Hows hematopoietic stem cell regulated by bone marrow niche?

Jin Hur


(Seoul National Univ.)

Clonal hematopoiesis in aplastic anemia

Hideki Makishima
(University of Kyoto, Japan)

Intragenic CpG islands play important roles in bivalent chromatin assembly of developmental genes

Young-Joon Kim
(Yonsei Univ.)

Immunological forces revive their sense of mission, driving the leukemia regression in AML marrow

Hee-Je Kim


(The Catholic Univ. of Korea)

Mosaicism or clonal heterogeneity in hematological malignancies is normally a poor prognostic marker any stage of disease

Hamish Scott


(Univ. of South Australia, Australia)

14:20-14:40Coffee Break
14:40-16:20KSH-EHA Joint Symposium: T-NHL?
Advances of treatment in extranodal NK/T-cell lymphoma, nasal type (ENKTL)

Won Seog Kim (Sungkyunkwan Univ.)

Frontline treatment of T-NHL, esp PTCL

Norbert Schmitz (Asklepios Hospital St. Georg, Germany)

Salvage treatment of PTCL

Deok-Hwan Yang (Chonnam National Univ.)

Role of transplantation in PTCL

Francesco dAmore (Aarhus Univ., Denmark)

16:20-16:50Special Education SessionSpecial Session: Legal Issues
?[16:20-16:50]
?자?전법의 ?해

구홍?/p>

(?료기????증??

16:50-17:00Break[16:50-17:20]
?료?고 ?해구제 ??료분쟁 조정 ?에 관??법이??br>

?학?/p>

(?국?료분쟁조정
중재??

17:00-18:00[ENG] Oral Presentation V[ENG] Oral Presentation VI[ENG] Oral Presentation VII[17:20-17:50]
?료분쟁 ?황 - ?액질환??중심?로

(?우로펌)

?재??/p>

18:00-18:30Poster Presentation (Emerald Hall, 3F)
18:30Welcome Reception (Grand Ballroom, Hotel 2F)



MAY 27th (Saturday)
?Room ARoom BRoom CRoom D
(Diamond Hall, 3F)
07:30-08:30Satellite Symposium III
[Breakfast]
Satellite Symposium IV
[Breakfast]
??
The evolving role of bispecific T-cell engaging immunotherapy in relapsed or refractory adult ALL

Johannes Dull
(Universitatsklinikum Wurzburg, Germany)

Emerging views on role of TPO-RA in management of cITP

Gregory Cheng


(Univ. of Macau, China)

08:30-09:30Oral Presentation VIIIOral Presentation IXOral Presentation XOral Presentation XI
09:30-10:50Scientific Session IV: Genetic Susceptibility to LukemiaScientific Session V: Updates on Multiple MyelomaScientific Session VI: Genetic EngineeringOral Presentation XII
Different concepts of genetic susceptibility to leukemia in children & adults: How to detect and recognize the variable phenotypes

Dongsoon Lee


(Seoul National Univ.)

[09:30-09:50]
Mechanism of IMIDs

Efstathios Kastritis


(National and Kapodistrian Univ. of Athens, Greece)

Biology and technical aspect of genome editing

eokjoong Kim (ToolGen)

?
Familial clustering of hematological malignancies: Harbingers of wider germline cancer susceptibility

Hamish Scott


(Univ. of South Australia, Australia)

[09:50-10:10]
Immune networks in MM

Je-Jung Lee


(Chonnam National Univ.)

Clinical application of genome editing

Ji Hyeon Ju


(The Catholic Univ. of Korea)

Management & consulting of patients with inherited predisposition to leukemia

Sun-Young Kong


(National Cancer Center)

[10:10-10:30]
Stromal cells in MM microenvironment: Focus on CXCL12

Deog-Yeon Jo


(Chungnam National Univ.)

Engineered T-cells for immunotherapy

Stephen M. Gottschalk


(Baylor College of Medicine, USA)

?[10:30-10:50]
Adaptive T cell therapy for multiple myeloma

최경??(?울??)

?
10:50-11:10Coffee Break
11:10-11:40Best Abstract Presentation?
11:40-12:20Plenary Lecture II
Recent advances in cell and gene therapy

Stephen M. Gottschalk (Baylor College of Medicine, USA)

12:20-12:50Award Ceremony & Closing Meeting

2017-03-27 5:21:20, ȸ : 648